Dr. Sumithra Vattigunta

Hematology
3401 Pga Blvd, Suite 200, 
Palm Beach Gardens, FL 
Offers Telehealth
3401 Pga Blvd, Suite 200, 
Palm Beach Gardens, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sumithra Vattigunta is a Hematologist in Palm Beach Gardens, Florida. Dr. Vattigunta is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Thrombocytopenia, Vitamin B12 Deficiency, and Non-Hodgkin Lymphoma.

Her clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Licenses
Internal Medicine in FL
Hospital Affiliations
Palm Beach Gardens Medical Center
Wellington Regional Medical Center
Jupiter Medical Center
Good Samaritan Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC
3401 Pga Blvd, Suite 200, Palm Beach Gardens, FL 33410
Other Locations
FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC
1309 N Flagler Dr, Florida Cancer Specialists, West Palm Beach, FL 33401
FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC
1037 S State Rd 7, 303 Florida Cancer Special, Wellington, FL 33414
FLORIDA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC
1970 Golf St, Sarasota, FL 34236

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Enrollment Status: Active_not_recruiting
Publish Date: December 10, 2025
Intervention Type: Drug
Study Drugs: tucatinib, T-DM1
Study Phase: Phase 3
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Drug, Other
Study Drug: Ribociclib
Study Phase: Phase 3
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients With HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug, Biological
Study Drugs: Margetuximab, Trastuzumab, Capecitabine, Eribulin, Gemcitabine, Vinorelbine
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Phase 2 Study of Paclitaxel in Combination With Reparixin Compared to Paclitaxel Alone as Front-line Therapy for Metastatic Triple- Negative Breast Cancer (FRIDA)
A Randomized, Double-blind, Placebo-controlled Phase 2 Study of Paclitaxel in Combination With Reparixin Compared to Paclitaxel Alone as Front-line Therapy for Metastatic Triple- Negative Breast Cancer (FRIDA)
Enrollment Status: Completed
Publish Date: September 16, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors
A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors
Enrollment Status: Withdrawn
Publish Date: September 06, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials
Similar Doctors
Distinguished in Lung Adenocarcinoma
Dr. Abraham Schwarzberg
Hematology | Oncology
Distinguished in Lung Adenocarcinoma
Dr. Abraham Schwarzberg
Hematology | Oncology

Cancer Center Of South Florida PLLC

1630 S Congress Ave, Suite 200, 
Palm Springs, FL 
 (14.5 miles away)
561-253-3980
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Abraham Schwarzberg is a Hematologist and an Oncologist in Palm Springs, Florida. Dr. Schwarzberg is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Distinguished in Lung Adenocarcinoma
Dr. Judah D. Friedman
Oncology | Hematology | Hematology Oncology
Distinguished in Lung Adenocarcinoma
Dr. Judah D. Friedman
Oncology | Hematology | Hematology Oncology

Florida Cancer Specialists And Research Institute, LLC

3401 Pga Blvd, Suite 200, 
Palm Beach Gardens, FL 
 (0.1 miles away)
561-366-4100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Judah Friedman is an Oncologist and a Hematologist in Palm Beach Gardens, Florida. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, and Bone Marrow Aspiration. Dr. Friedman is currently accepting new patients.

Distinguished in Lung Adenocarcinoma
Dr. Edgardo S. Santos
Hematology Oncology | Hematology | Oncology
Distinguished in Lung Adenocarcinoma
Dr. Edgardo S. Santos
Hematology Oncology | Hematology | Oncology

The Oncology Institute Fl, LLC

500 Se 17th St 1st Floor, Suite 100, 
Fort Lauderdale, FL 
 (51.7 miles away)
754-202-3460
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Edgardo Santos is a Hematologist Oncology specialist and a Hematologist in Fort Lauderdale, Florida. Dr. Santos is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, and Large-Cell Lung Carcinoma. Dr. Santos is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Vattigunta's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 43 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile